Sign In


D3-creatine dilution to assess skeletal muscle mass in colon cancer patients

Among colon cancer patients participating in a resistance training intervention during chemotherapy, this study will examine whether a new method to evaluate skeletal muscle mass (d3-creatine dilution) is associated with the key cancer outcomes of strength and physical function, chemotherapy toxicity, inflammation, cardiometabolic risk factors and markers of tumor recurrence.
Investigator: Feliciano, Elizabeth
Funder: National Cancer Institute